Molecular Biophysics and Pharmacology

Finished projects

Bioinorganic chemistry for the design of new medicines

Programme name: European Commission, FP7, ERC-2009-AdG_20090325
Coordinator: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic
Years: 2010 - 2015
Solver: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic

Metallo-Drug Design and Action

Programme name: COST – European Cooperation in Science and Technology (EC/NSF)
Coordinator: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic
Investigator: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic
Years: 2006 - 2011
States participating: AT, BE, CHE, DE, DK, ES, FR, GR, HU, IE, IL, IT, NL, NO, PL, PT, RO, SE, SI, TR, UK

Platinum and ruthenium compounds. From DNA damage to cancer chemotherapy

Programme name: Grants for Biomedical Research (Howard Hughes Medical Institute, USA)
Coordinator: Jana Kašpárková, Institute of Biophysics, AS CR, Brno
Years: 2006 - 2010

Platinum and ruthenium complexes. From DNA damage to cancer chemotherapy

Programme name: Collaborative Research Initiative Grant (The Wellcome Trust)
Coordinator: N/A
Investigator: Viktor Brabec, IBP, AS CR, Brno and
Years: 2005 - 2008
States participating: United Kingdom

Mechanistic Studies on New Platinum Clinical Agents

Programme name: National Institutes of Health, NIH, USA
Coordinator: Nicholas P. Farrell, Virginia Commonwealth University, Richmond, USA
Investigator: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic
Years: 1998 - 2007
States participating: USA

Basis for new structure-pharmacological relationship of platinum drugs

Programme name: Grants for Biomedical Research (HHMI, USA)
Coordinator: Jana Kašpárková, Institute of Biophysics, AS CR, Brno
Years: 2001 - 2005

Platinum metal complexes as DNA-protein cross-linking agents

Programme name: National Science Foundation (USA) Academy of Sciences of the Czech Republic
Coordinator: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic
Investigator: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic
States participating: USA

Transition metal-based anticancer compounds. From mechanistic studies to innovatory cancer chemotherapy

Programme name: Ministry of Education of the CR/Ministry of Education of China
Coordinator: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic
Investigator: Viktor Brabec, Institute of Biophysics, AS CR, Brno, Czech Republic
States participating: China